These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15486993)

  • 1. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC; DeWille JW
    Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
    Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS; Nagle RB; Bowden GT
    Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells.
    Chen T; Wang LH; Farrar WL
    Cancer Res; 2000 Apr; 60(8):2132-5. PubMed ID: 10786674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.
    Tsui KH; Lin YF; Chen YH; Chang PL; Juang HH
    J Androl; 2011; 32(4):383-93. PubMed ID: 21051589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mouse C/EBPdelta gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression.
    Zhang Y; Sif S; DeWille J
    J Cell Biochem; 2007 Dec; 102(5):1256-70. PubMed ID: 17471507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.
    Zhang F; Li C; Halfter H; Liu J
    Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
    Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
    Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
    Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
    Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
    Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
    Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
    Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference targeting Stat3 inhibits growth and induces apoptosis of human prostate cancer cells.
    Lee SO; Lou W; Qureshi KM; Mehraein-Ghomi F; Trump DL; Gao AC
    Prostate; 2004 Sep; 60(4):303-9. PubMed ID: 15264241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-talk between signal transducer and activator of transcription 3 and androgen receptor signaling in prostate carcinoma cells.
    Matsuda T; Junicho A; Yamamoto T; Kishi H; Korkmaz K; Saatcioglu F; Fuse H; Muraguchi A
    Biochem Biophys Res Commun; 2001 Apr; 283(1):179-87. PubMed ID: 11322786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells.
    Ni Z; Lou W; Leman ES; Gao AC
    Cancer Res; 2000 Mar; 60(5):1225-8. PubMed ID: 10728680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.